Publications 2017


“Motor Imagery as a Function of Disease Severity in Multiple Sclerosis: An fMRI Study.”
A Tacchino, C Saiote, G Brichetto, G Bommarito, L Roccatagliata, C Cordano, MA Battaglia, GL Mancardi, Inglese M. Front Hum Neurosci. 11: 628 doi: 10.3389/fnhum.2017.00628 (2017)

“Neck Vessel Cross-Sectional Area Measured with MRI: Scan-Rescan Reproducibility for Longitudinal Evaluations.” L Pelizzari, MM Laganà, D Jakimovski, N Bergsland, J Hagemeier, G Baselli, R Zivadinov. Journal of Neuromaging 28: 48–56 doi: 10.1111/jon.12488 (2017)

“Cortical and Subcortical Morphometric and Iron Changes inRelapsing-Remitting Multiple Sclerosis and Their Association withWhite Matter T2 Lesion Load.” A Al-Radaideh, I Athamneh, H Alabadi, M Hbahbih. Clin Neuroradiol doi: 10.1007/s00062-017-0654-0 (2017).

“Cervical Cord Atrophy and Long-Term Disease Progression in Patients with Primary-Progressive Multiple Sclerosis.” FX Aymerich, C Auger, J Alonso, M Alberich, J Sastre-Garriga, M Tintoré, X Montalban, A Rovira. AJNR doi: 10.3174/ajnr.A5495 (2017).

“Evidence of Progressive Tissue Loss in the Core of Chronic MS lesions: A Longitudinal DTI Study.” A Klistorner, C Wang, C Yiannikas, J Parratt, M Dwyer, J Barton, SL Graham, Y Youa, S Liu, MH Barnett. NeuroImage: Clinical doi: 10.1016/j.nicl.2017.12.010 (2017).

“Lower Arterial Cross-Sectional Area of Carotid and Vertebral Arteries and Higher Frequency of Secondary Neck Vessels Are Associated with Multiple Sclerosis.” P Belov, D Jakimovski, J Krawiecki, C Magnano, J Hagemeier, L Pelizzari, B Weinstock-Guttman, R Zivadinov. AJNR doi: 10.3174/ajnr.A5469 (2017).

“Pronounced Structural and Functional Damage in Early Adult Pediatric-Onset Multiple Sclerosis with No or Minimal Clinical Disability.” A Giorgio, J Zhang, ML Stromillo, F Rossi, M Battaglini, L Nichelli, M Mortilla, E Portaccio, B Hakiki, MP Amato, N De Stefano. Frontiers in Neurology 8: 608 (2017).

“Cardiac Remodelling in Patients Undergoing in-Centre Nocturnal Haemodialysis: Results from the MIDNIGHT Study, a Non-Randomized Controlled Trial.” MPM Graham-Brown, DR Churchward, KL Hull, R Preston, WP Pickering, HC Eborall, GP McCann, JO Burton. Blood Purif 44:301-310 (2017).

“A Two-Year Study Using Cerebral Gray Matter Volume to Assess the Response to Fingolimod Therapy in Multiple Sclerosis.” F Yousuf, SL Dupuy, S Tauhid, R Chu, G Kim, S Tummala, F Khalid, T Chitnis, BC Healy, R Bakshi. Journal of the Neurological Sciences doi:10.1016/j.jns.2017.10.019 (2017).

“Efficacy of Fingolimod and Interferon Beta-1b on Cognitive, MRI, and Clinical Outcomes in Relapsing–Remitting Multiple Sclerosis: an 18-Month, Open-Label, Rater-Blinded, Randomised, Multicentre Study (the GOLDEN Study).” G Comi, F Patti, MA Rocca, FC Mattioli, MP Amato, P Gallo, D Centonze, C Pozzilli, F Saccà, FT Bergh, M Bartezaghi, R Turrini, M Filippi, Golden Study Group.
Journal of Neurology 1-14 doi: 10.1007/s00415-017-8642-5 (2017).

“Mesenchymal Stem Cells and Conditioned Media in the Treatment of Multiple Sclerosis Patients: Clinical, Ophthalmological and Radiological Assessments of Safety and Efficacy.” S Dahbour, F Jamali, D Alhattab, A Al-Radaideh, O Ababneh, N Al-Ryalat, M Al-Bdour, B Hourani,M Msallam, M Rasheed, A Huneiti, Y Bahou, E Tarawneh, A Awidi. CNS Neurosci Ther. 23:866-874 doi:10.1111/cns.12759 (2017).

“CSF β-amyloid and White Matter Damage: a New Perspective on Alzheimer’s Disease.” AM Pietroboni, M Scarioni, T Carandini, P Basilico, M Cadioli, G Giulietti, A Arighi, M Caprioli, L Serra, C Sina, C Fenoglio, L Ghezzi, GG Fumagalli, MA De Riz, A Calvi, F Triulzi, M Bozzali, E Scarpini, D Galimberti. JNNP doi:10.1136/jnnp-2017-316603 (2017).

“Neuroinflammation and its Relationship to Changes in Brain Volume and White Matter Lesions in Multiple Sclerosis.” G Datta, A Colasanti, EA Rabiner, RN Gunn, O Malik, O Ciccarelli, R Nicholas, Van Vlierberghe, W Van Hecke, G Searle, A Santos-Ribeiro, PM Matthews. Brain awx228 (2017).

“Relation Between Characteristics of Carotid Atherosclerotic Plaques and Brain White Matter Hyperintensities in Asymptomatic Patients.” E Ammirati, F Moroni, M Magnoni, MA Rocca, R Messina, N Anzalone, C De Filippis, I Scotti, F Besana, P Spagnolo, OE Rimoldi, R Chiesa, A Falini, M Filippi, PG Camici. Nature Scientific Reports 7: doi:10.1038/s41598-017-11216-x (2017).

“Cognitive Fatigue in Individuals with Traumatic Brain Injury is Associated with Caudate Activation.” G. R. Wylie, E Dobryakova, J DeLuca, N Chiaravalloti, K Essad, H Genova. Nature Scientific Reports 7: doi: 10.1038/s41598-017-08846-6 (2017).

“Cerebellar Lobule Atrophy and Disability in Progressive MS.” S Cocozza, M Petracca, E Mormina, K Buyukturkoglu, K Podranski, MM Heinig, G Pontillo, C Russo, E Tedeschi, CV Russo, T Costabile, R Lanzillo, A Harel, S Klineova, A Miller, A Brunetti, V Bresci Morra, F Lublin, M Inglese. J Neurol Neurosurg Psychiatry doi: 10.1136/jnnp-2017-316448 (2017).

“The Relationship Between Cortical Lesions and Periventricular NAWM Abnormalities Suggests a Shared Mechanism of Injury in Primary-Progressive MS.” M Pardini, M Petracca, A Harel, L Fleysher, N Oesingmann, G Bommarito, M Fabian, D Chard, F Lublin, M Inglese. NeuroImage: Clinical DOI: 10.1016/j.nicl.2017.07.001 (2017).

“Volumetric Analysis from a Harmonized Multisite Brain MRI Study of a Single Subject with Multiple Sclerosis.” RT Shinohara, J Oh, G Nair, PA Calabresi, C Davatzikos, J Doshi, RG Henry, G Kim, KA Linn, N Papinutto, D Pelletier, DL Pham, DS Reich, W Rooney, S Roy, W Stern, S Tummala, F Yousuf, A Zhu, NL Sicotte, R Bakshi. AJNR Am J Neuroradiol doi: 10.3174/ajnr.A5254 (2017).

“Recovery of Slow-5 Oscillations in a Longitudinal Study of Ischemic Stroke Patients.” C La, VA Nair, P Mossahebi, J Stamm, R Birn, ME Meyerand, V Prabhakaran. NeuroImage Clinical 17:398-407 (2017).

“Superior Cerebellar Peduncle Atrophy Predicts Cognitive Impairment in Relapsing Remitting Multiple Sclerosis Patients with Cerebellar Symptoms: A DTI Study.” G Nicoletti1, P Valentino, C Chiriaco, A Granata, S Barone, E Filippelli, ME Caligiuri, B Vescio, A Sarica, A Quattrone. Journal of Multiple Sclerosis 4(2) DOI: 10.4172/2376-0389.1000202 (2017).

“Using DTI to Assess White Matter Microstructure in Cerebral Small Vessel Disease (SVD) in Multicentre Studies.” ID Croall, V Lohner, B Moynihan, U Khan, A Hassan, JT O’Brien, RG Morris, DJ Tozer, VC Cambridge, K Harkness, DJ Werring, AM Blamire, GA Ford, TR Barrick, HS Markus. Clin Sci (Lond). 131(12): 1361-1373 (2017).

“Non Invasive Imaging Assessment of the Biodistribution of GSK2849330, an ADCC and CDC Optimized Anti HER3 mAb, and its Role in Tumor Macrophage Recruitment in Human Tumor-Bearing Mice.” H Alsaid, T Skedzielewski, MV Rambo, K Hunsinger, B Hoang, W Fieles, ER Long, J Tunstead, DJ Vugts, M Cleveland, N Clarke, C Matheny, BM Jucker. PLoS One 12(4): e0176075 (2017).

“Synchronization and Variability Imbalance Underlie Cognitive Impairment in Primary-Progressive Multiple Sclerosis.” M Petracca, C Saiote, HA Bender, F Arias, C Farrell, P Magioncalda, M Martino, A Miller, G Northoff, F Lublin, M Inglese. Nature Scientific Reports DOI: 10.1038/srep46411 (2017).

“Natalizumab Stabilizes Physical, Cognitive, MRI, and OCT Markers of Disease Activity: A Prospective, Non-Randomized Pilot Study.” GD Talmage, Oscar JM Coppes, A Javed, J Bernard. PLoS One DOI: (2017).

“Detection of Focal Longitudinal Changes in the Brain by Subtraction of MR Images.” N Patel, MA Horsfield, C Banahan, AG Thomas, M Nath, J Nath, PB Ambrosi, EM Chung. AJNR Am J Neuroradiol. DOI: 0.3174/ajnr.A5165 (2017).

“Magnetic Resonance Imaging Plaque Hemorrhage for Risk Stratification in Carotid Artery Disease With Moderate Risk Under Current Medical Therapy.” AA Hosseini, RJ Simpson, N Altaf, PM Bath, ST MacSweeney, DP Auer. Stroke DOI: 10.1161/STROKEAHA.116.015504 (2017).

“Relationship Between White Matter Hyperintensities Volume and the Circle of Willis Configurations in Patients with Carotid Artery Pathology.” L Saba, R Sanfilippo, M Porcu, P Lucatelli, R Montisci, F Zaccagna, J Suri, M Anzidei, M Wintermark. European Journal of Radiology DOI: j.ejrad.2017.01.031 (2017).

“Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington’s Disease.” I Rattray, EJ Smith, WR Crum, TA Walker, R Gale, GP Bates, M Modo. PLoS One DOI: 10.1371/journal.pone.0168556 (2017).

“The Effect of Glatiramer Acetate on Spinal Cord Volume in Relapsing-Remitting Multiple Sclerosis.” T Singhal, S Tauhid, S Hurwitz, M Neema, R Bakshi. Journal of Neuroimaging doi: 10.1111/jon.12378 (2017).

“Association Between Serum MicroRNAs and Magnetic Resonance Imaging Measures of Multiple Sclerosis Severity.” K Regev, BC Healy, F Khalid, A Paul, R Chu, S Tauhid, S Tummala, C Diaz-Cruz, R Raheja, MA Mazzola, F von Glehn, P Kivisakk, SL Dupuy, G Kim, T Chitnis, HL Weiner, R Gandhi, R Bakshi. JAMA Neurology DOI: doi:10.1001/jamaneurol.2016.5197 (2017).

“An Abnormal Periventricular Magnetization Transfer Ratio Gradient Occurs Early in Multiple Sclerosis.” JW Brown, M Pardini, WJ Brownlee, K Fernando, RS Samson, F Prados Carrasco, S Ourselin, CA Gandini Wheeler-Kingshott, DH Miller, DT Chard. Brain DOI: 10.1093/brain/aww296 (2017).

“Silica-Coated Metal Chelating-Melanin Nanoparticles as a Dual-Modal Contrast Enhancement Imaging and Therapeutic Agent.” S Cho, W Park, D-H Kim. ACS Applied Materials and Interfaces 9, 101–111 (2017).

“Analysis of Ageing-Associated Grey Matter Volume in Patients with Multiple Sclerosis Shows Excess Atrophy in Subcortical Regions.” CA Bishop, RD Newbould, JSZ Lee, L Honeyfield, R Quest, A Colasanti, R Ali, M Mattoscio, A Cortese, R Nicholas, PM Matthews, PA Muraro, AD Waldman. NeuroImage: Clinical 13:9-15 (2017).